The association of ethnicity and oncologic outcomes for oral cavity squamous cell carcinoma (OSCC)

Introduction

Head and neck cancer is the sixth most common cancer worldwide and is the most common neoplasm in South Asia (1). Oral cavity cancers account for 30% of all head and neck cancers and 90% of these are oral squamous cell carcinomas (OSCCs) (2,3). These cancers include tumours of the floor of the mouth, anterior tongue, alveolar ridge, retromolar trigone, the hard palate, and the buccal mucosa. According to the World Health Organization, of the 267,000 newly diagnosed OSCCs worldwide, close to 40% occurred in South Asia (India, Pakistan, Bangladesh, and Sri Lanka). Furthermore, oral cancer incidence and mortality rates in South Asia are almost twice those of global rates (4).

There are a variety of factors that are known to contribute to the development of OSCCs including the consumption of tobacco and alcohol, dental trauma, and human papilloma virus (5). The predominance of OSCCs in South Asia is often attributed to the use of betel nut (6), which can be consumed in a variety of ways but is most often dried and ground into a powder and wrapped in a package known as betel quid or pan, comprised of a mixture of slaked lime, flavouring, and tobacco. Its use is influenced by social acceptability, religious beliefs, and stimulant properties. Betel quid is often stored inside the cheek for hours similar to chewing tobacco. The slaked lime, most often used in India, is particularly problematic as it causes oxidative DNA damage and local mucosal abrasion creating deeper exposure to the carcinogenic components (7).

Although there have been improvements in the quality of life of patients with OSCC, both the disease itself as well as its treatment remain morbid with a 5-year overall survival rate of 50 to 60% (8). Current treatments include surgical resection, radiotherapy, chemotherapy, or a combination of these modalities. The primary treatment for early-stage (stage I and II) and advanced-stage (stage III and IV) OSCC is surgical resection of the tumor (9). Previous North American studies have looked at the differences in head and neck cancer disease outcomes according to ethnicity, showing large disparity in mortality rates among African American versus white patients in the United States (10-12). These differences have been attributed to a combination of tumour stage at time of presentation, access to healthcare, and exposure to carcinogens. Nichols et al., reported that even after controlling for tumour stage at time of presentation, African American patients had poorer outcomes, suggesting other intrinsic and extrinsic factors such as genetics and socioeconomic status influence survival in OSCC (13). Arbes et al., accounted for socioeconomic status, which resulted in elimination of the survival disadvantage observed among black patients (14). To date, however, there has been little research that compares oncological outcomes of patients of South Asian (SA) ethnicity with OSCCs compared to other ethnicities.

Our regional cancer centre, based in Calgary, Alberta, Canada, treats a high volume of OSCC, in patients with diverse ethnic backgrounds. SA patients represent a significant proportion of patients treated. Given the increased incidence and mortality rates of patients with OSCC in India, the objective of this study was to characterize oncological outcomes among patients of SA ethnicity within our centre and compare these outcomes to patients with OSCC who are not of SA ethnicity.

Methods and Material

Results

Using the previously described approach for selecting SA patients, we identified 64 SA patients and 632 non-SA patients, which served as the comparison group. We were unable to classify 1 patient as either SA or non-SA (Figure 1). Of the 697 patients that were included, 9% (n=64) were of SA ethnicity. Table 1 describes the cohort by patient and tumour characteristics stratified by ethnicity. The median follow-up time was 36.4 months (SD=31.02). SA patients were significantly younger and were less likely to smoke or drink. There were no differences in tumor pathologic characteristics (T-stage, N-stage, ENE, LVI, PNI), nor in the use of adjuvant radiation between the SA and non-SA patients.

Discussion

This study demonstrated that patients of SA ethnicity had significantly worse survival outcomes and were twice as likely to recur compared to non-SA patients even after accounting for other known factors contributing to poor oncological outcomes. The SA community is one of the largest and fastest growing minority groups in Canada based on the 2021 census (26). Considering the migration patterns within the South Asian community and their correlation with the prevalence of OSCC, it’s important to acknowledge the potential impact on health trends in Canada. Understanding these patterns, can help promote public health initiatives and ensure that the unique needs of the South Asian population are met, fostering a more inclusive and supportive environment. Studies conducted in Malaysia (27,28), UK (29), Australia (30), and South Africa (31) indicate that individuals of SA heritage are at higher risk of oral cancer than the non-SA population in those countries. A study in British Columbia, which has one of the highest South Asian immigrant populations in Canada, demonstrated a relative risk of developing OSCC of 1.33 and 1.66 for South Asian men and women, respectively, as compared with the non-SA population (32). Anecdotally, the senior authors at our centre, who treat high volumes of OSCC, felt that year over year, SA patients represented a disproportionately larger ethnicity group than other ethnicities, and were recurring more frequently. The decision to formally evaluate outcomes based on SA ethnicity was therefore born out of concern for a potentially at-risk population, in hopes to validate the need for a more tailored approach to treating this group of patients, as well as to build awareness and inform public health policy.

This study uniquely evaluates differences in oncological outcomes of patients of SA ethnicity affected by OSCCs compared to patients of non-SA ethnicity. This results suggest that, in Canada, SA ethnicity is an independent predictor of recurrence-free and worse disease-specific survival, when compared to non-SA patients. The study is conducted within the framework of a regional cancer center, where a dedicated multidisciplinary team, possessing expert training and extensive experience, oversees the management of all head and neck cancers. This setup intentionally minimizes bias for selection for more complicated cases. Stage of diagnosis is regarded as one of the most important predictors of oral cancer survival with a significantly improved 5-year survival rate for early-stage disease (71.4%) than for late-stage disease (21.8%) (33). In this study, when comparing baseline characteristics of SA and non-SA patients, oncological parameters such as T-Stage, N-stage, ENE, LVI and PNI were similar which suggests they were not the primary drivers of differences in recurrence and worse survival in SA patients. This association was also found in multivariable analysis. The similarity in these variables between groups also infers that there are no discrepancies in access to care, which would likely lead to a delayed presentation, with more advanced disease at time of presentation. Although, the initial presenting burden of disease is an imperfect tool to estimate access to care, in a universal health care system, issues such as treatment delay, is relatively uniform across all sub-populations. Interestingly, features that are typically protective against developing OSCC such as younger age and non-smoking status were more common in SA patients. Despite this, being SA resulted in a two-fold increase in recurrence and decrease in OSCC survival. As expected, patients with advanced T stage (T3/4), nodal disease and ENE had both worsened DSS and RFS, validating that the patient cohort in this study is representative of the greater head and neck cancer population. Disease stage at time of diagnosis has been previously identified as a causative factor in poorer oncological outcome in minority groups (34). In this study, even after controlling for disease stage, SA ethnicity remained as an independent factor in predicting survival and recurrence.

Several factors potentially contribute to the poorer outcomes of OSCC in SA patients. One of the major factors is thought to be the use of betel nut in the SA culture, which is commonly consumed in the form of betel quid. Although the added tobacco plays a significant role in the development of OSCCs, studies have suggested that betel products, which contain arecoline and 3-(methylnitrosamino) propionitrile, may have an independent carcinogenic effect (35) resulting in malignant transformation of oral submucosal fibrosis (OSMF). The potential for malignant transformation resulting in OSCC has been reported to be as high as 7 to 13% (36). Although the exact mechanism is not well understood, betel nut is thought to induce c-jun proto-oncogene expression in human mucosal fibroblasts (37). The fibrosis itself can result in decreased vascularity and hypoxia thus mediating mutated cell divisions (38). This study did not find any differences on either recurrence or survival among patients of SA ethnicity based on betel nut use; however, given that betel nut consumption was not consistently reported in patient charts, further investigation with larger numbers and more consistent reporting is required to verify this finding.

Pattern of recurrence describes whether a patient recurs locally, regionally, or at a distant site. Given that betel nut is often stored inside the cheek for prolonged periods of time, one would expect SA patients to recur locoregionally if betel nut use is the causative factor. In our study population, the majority of recurrences in the SA population were local/regional however, the proportion of patients that recurred locoregionally was not significantly different between SA and non-SA patients. This suggests that regardless of the causative agent for OSCC, recurrences are more likely to manifest as local/regional rather than distant disease.

A strength of this study relies on the rigorous, prospective collection of data including patient related factors, tumor factors, treatment factors and oncologic outcomes. A limitation is the relatively small sample size within the SA cohort. A larger multicentre study could yield more definitive results on this issue. Given the absence of race or ethnicity information in many databases used in health research, surnames are frequently employed as a proxy when investigating healthcare patterns within ethnic populations. Despite this, a limitation arises in potentially excluding individuals of South Asian background who may have undergone name changes. However, it should be noted that in Canada, according to the 2021 census, 76% of South Asians were recent immigrants born outside of Canada (26), and therefore, the likelihood of experiencing a name change is low. This study also did not differentiate between SA immigrants and Canadian born people of SA ethnicity (first and subsequent generations) which hinders the ability to distinguish between the role of environment versus inheritance on the findings. There are important factors related to immigration status that may mediate the findings of this study, some of which include betel nut use, environmental factors and genetic factors. Although, there is no specific data on the use of betel nut in Canada, UK and Australian data shows that it is commonly used among first generation immigrants and its use is reduced in subsequent generations (39). However, in younger generations, the form of consumption is tilting towards ingestion which may result in higher rates of esophageal cancers (39). As such, a more granular study on time since immigration and mode of betel nut use would be informative. In addition to environmental factors, genetics can also play a role in the poor outcomes observed in South Asian patients with OSCC. However, no specific genes have been identified as predisposing factors for OSCC in the SA population and the hereditary factors that contribute to the disease are largely unknown. While most cases of OSCC occur sporadically, certain families with a high preponderance of the disease have been found to carry oncogenes such as VAV2 and IQGAP1 with an autosomal dominance penetrance (40). Moreover, with the emergence of precision medicine, there has been a growing interest in identifying diagnostic and prognostic biomarkers for OSCC. One such biomarker is microRNA (miRNA), a large group of small single-stranded non-coding endogenous RNAs that play a role in post-transcriptional gene regulation. Upregulation of miRNAs is thought to contribute to OSCC resistance to chemoradiation and recurrence (41). Our centre is involved in banking the tumors of all consecutive OSCC patients and intends to explore the potential molecular basis of poor OSCC outcomes in the SA population.

The findings of this study reveal that patients with SA ethnicity experience significantly poorer outcomes compared to the non-SA cohort, even after accounting for other predictors of poor outcome. To gain a more comprehensive understanding of the intricate interplay between ethnicity, environmental exposure, and genetic predisposition in OSCC outcomes, further research is imperative. Such research could pave the way for personalized treatment decisions and patient counseling, as well as the formulation of public health policies that serve to assist vulnerable and at-risk populations.

Conclusion

Patients of SA ethnicity had worse outcomes (higher risk of recurrence and worsened survival) than patients with non-SA ethnicity, even after controlling for other known predictors of poor outcome in OSCC. These finding can inform more individualized treatment decision making and impact public health policy when serving heterogeneous patient populations.